Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia

Peptides. 1994;15(2):243-5. doi: 10.1016/0196-9781(94)90009-4.

Abstract

Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) and MIF-1 (Pro-Leu-Gly-NH2) act as opiate antagonists in various behavioral systems including ingestion. Central injection of peptide YY (PYY) elicits a powerful feeding response in satiated rats, and the opioid antagonist naloxone decreases eating in a variety of conditions including PYY-stimulated eating. Therefore, the aim of this study was to examine the effects of Tyr-MIF-1 and MIF-1 as opiate antagonists on a naloxone-sensitive PYY model of hyperphagia. Naloxone at doses of 1.0 and 10.0 mg/kg, SC, decreased hyperphagia induced by 2.4 micrograms PYY injected in the PVN. MIF-1 and Tyr-MIF-1 had no effect on PYY-induced eating at doses comparable to naloxone (0.1 to 10.0 mg/kg, IP). These results suggest that in this model of eating behavior, Tyr-MIF-1 and MIF-1 do not act as opiate antagonists.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Feeding Behavior / drug effects
  • Hyperphagia / chemically induced*
  • MSH Release-Inhibiting Hormone / analogs & derivatives
  • MSH Release-Inhibiting Hormone / pharmacology*
  • Male
  • Naloxone / pharmacology*
  • Peptide YY
  • Peptides / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Peptides
  • Peptide YY
  • Naloxone
  • tyrosyl-prolyl-leucyl-glycinamide
  • MSH Release-Inhibiting Hormone